Leading Australian pharmacist and Bellberry board member, Emeritus Professor Lloyd Sansom, has been awarded one of the profession’s highest international honours, the International Pharmaceutical Federation’s (FIP) André Bédat Award. The award is given in recognition of an outstanding contribution to pharmaceutical practice, and is awarded every 2 years.
Lloyd joined Bellberry as a board member in 2012 and has been an invaluable contributor to the Bellberry team. In 2014, he played a pivotal part in the ‘Challenges of Early Crossover in Clinical Trial Design for Oncology’ conference which Bellberry hosted. The conference resulted in the formation of a Scientific Advisory Committee which consisted of an international panel of experts and was chaired by Lloyd. The Advisory Committee developed best practice guidelines for trial design and statistical methods which were published by the International Journal of Technology Assessment in Health Care (Cambridge University Press).
Lloyd is a distinguished educator, researcher and policy advisor and has an illustrious career in health and pharmacy. He has a particular research interest in pharmacokinetics, biopharmaceutics, the quality use of medicines and pharmaceutical policy.
The Bellberry team would like to extend their many congratulations to Lloyd on being awarded this prestigious honour. Further information on the award can be found here.